e1224

Small moleculeexperimental

Clinical trial activity

3 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Jun 1, 2011 (NCT01489228)

Timeline

2010s

  1. Jan 1, 2011

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • e1224

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03378661Phase 2Nov 30, 2016Centre de Recerca en Salut Internacional de Barcelona, Spain., Drugs for Neglected Diseases Initiative, Oswaldo Cruz Foundation
NCT03892213Phase 1Oct 31, 2014Drugs for Neglected Diseases Initiative, FP Clinical Pharma S.R.L., PHINC DEVELOPMENT
NCT01489228Phase 2Jun 1, 2011Centre de Recerca en Salut Internacional de Barcelona, Spain., Drugs for Neglected Diseases Initiative, Eisai, Universidad Mayor San Simón, Cochabamba, Bolivia.
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Drugs for Neglected Diseases InitiativeAcademic/Hospital3322011
Centre de Recerca en Salut Internacional de Barcelona, Spain.Academic/Hospital2012011
EisaiFor profit1012011
FP Clinical Pharma S.R.L.For profit1012014
Oswaldo Cruz FoundationAcademic/Hospital1012016
PHINC DEVELOPMENTFor profit1012014
Universidad Mayor San Simón, Cochabamba, Bolivia.Academic/Hospital1012011
7 organizations
Page 1 / 1